Microspheres comprising protein and showing injectability at high concentrations of said agent

Details for Australian Patent Application No. 2005244840 (hide)

International Classifications

Event Publications

9 November 2006 PCT application entered the National Phase

PCT publication WO2005/112893 Priority application(s): WO2005/112893

22 February 2007 Amendment Made

The nature of the amendment is: Amend co-inventor name from Biesker-Leib, Vered to Bisker-Leib, Vered

1 September 2011 Application Accepted

Published as AU-B-2005244840

12 January 2012 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 15 Nov 2011. Address for service in Australia - Peter Maxwell & Associates Level 6 60 Pitt Street Sydney NSW 2000 2005297570 3,6-substituted 5-arylamino-1H-pyridine-2-one derivatives and related compounds as poly(ADP-ribose)polymerase (PARP) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis Sanofi-Aventis Deutschland GmbH The nature of the amendment is as shown in the statement(s) filed 14 Nov 2011. Addre

10 May 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 15 Nov 2011

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.